CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages

AIM: To evaluate the diagnosis value of serum human epididymis protein 4 (HE4), cancer antigen 125 (CA125), the Risk of Ovarian Malignancy Algorithm (ROMA), and Copenhagen Index (CPH-I) at early stages for differentiating borderline ovarian tumors from epithelial ovarian cancer. METHODS: We recruite...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dis Markers
Main Authors: Wang, Zhiheng, Tao, Xiang, Ying, Chunmei
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6815620/
https://ncbi.nlm.nih.gov/pubmed/31737130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6241743
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados